Zimmer Biomet Shoulder Arthroplasty PMCF
Eligible age
20+ yrs
Accepts
All genders
Locations
11 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.
Sponsor: Zimmer Biomet
You may qualify if…
- ✓ Patient must be 20 years of age or older.
- ✓ Patient must be anatomically and structurally suited to receive shoulder arthroplasty implants.
- ✓ Patient is a candidate for shoulder arthroplasty due to one or more of the following:
- ✓ Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
- ✓ Rheumatoid arthritis.
- ✓ Correction of functional deformity.
- ✓ Fractures of the proximal humerus, where other methods of treatment are deemed inadequate.
- ✓ Difficult clinical management problems, where other methods of treatment may not be suitable or may be inadequate.
You may not qualify if…
- ✕ Patient is unwilling or unable to give consent or to comply with the follow-up program.
- ✕ Patient has any condition which would in the judgement of the Investigator, place the patient at undue risk or interfere with the study.
- ✕ Patient is known to be pregnant or breastfeeding.
- ✕ Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, and/or anticipated to be non-compliant).
- ✕ Patient is uncooperative or patient with neurologic disorders who is incapable or unwilling to follow directions.
- ✕ Patient has any sign of infection affecting the shoulder joint or in its proximity which may spread to the implant site.
- ✕ Patient has rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram.
- ✕ Patient has any neuromuscular disease compromising the affected limb that would render the procedure unjustifiable.
Where it's recruiting
Irvine
Golden
Chicago
Louisville
Royal Oak
Bloomington
Jackson
City of Saint Peters · St Louis
Buffalo
Philadelphia
Murray
Source: ClinicalTrials.gov · NCT04984291 · last updated 2026-04-28